Amzak Health
Venture capitalNew York · Seed–Late Stage · 4 people tracked
Find your way into Amzak Health
830 people in our graph share verified history with the Amzak Health team — schools, employers, funds. One of them is your warm intro.
Investment thesis
Amzak Health invests in life science innovation, targeting first-in-class and best-in-class technologies within medtech and biotech. The firm positions itself as more than just capital, acting as a partner to its portfolio companies and working alongside management teams to help them succeed. It operates as a small team of biotech and medtech investors with substantial investing and operating experience and a track record of success.
Source: firm website, verified Aug 3, 2026.
Team · 4 people
from the firm's website & public directories
What they invest in
from 24 of 25 portfolio companiesHealthtech ×18Medical Devices ×16Biotech ×11Hardware ×7Deep Tech ×2Digital Health ×2FemTech ×2AI & Machine Learning ×1
HQs:United States×13Germany×1United Kingdom×1Vietnam×1
Who they back
founder profiles across 7 portfolio companiesWhere their founders worked beforefrom 11 founders with career history
Dalhousie University ×4Harvard Medical School ×2Sound Blade Medical Inc. ×2
Investments · 25 tracked
founders shown can be your intro pathBy year:2026 · 12025 · 22024 · 42023 · 22021 · 12020 · 32019 · 12016 · 12015 · 116 dated
4DMT is a late-stage biotechnology company that develops gene delivery systems and genetic therapeutics targeting specific tissue types for various diseases.
BiotechHealthtechEmeryville, US
David Kirn(Executive Officer, Director)inDavid Schaffer(Director)inTheresa Janke(Executive Officer)in
BoardSharon Tetlow(Director)Margi McLoughlin(Director)
Co-investorsBerkeley CatalystBOLD LongevityChiesi VenturesPappas CapitalPfizer Venture InvestmentsBiotechnology Value Fund+3 more
Monte Rosa develops molecular glue degrader (MGD) therapeutics using MGD chemistry, artificial intelligence, structural biology, and proteomics to target previously undruggable or inadequately drugged disease targets.
AI & Machine LearningBiotechDeep TechHealthtechBoston, US
Markus Warmuth(M.D., Chief Executive Officer)inSharon Townson(Ph.D., Chief Scientific Officer)inJohn Castle(Ph.D., Chief Data and Information Officer)inFilip Janku(M.D., Ph.D., Chief Medical Officer)inPhil Nickson(Ph.D., J.D., Chief Business and Legal Officer)inMagnus Walter(DPhil, Chief Technology Officer)in
Co-investorsAisling CapitalNew Enterprise Associates (NEA)Versant VenturesHBM PartnersAvoro Capital AdvisorsGV (Google Ventures)+1 more
Teleflex is a medical device company.
Medical Devices
Stuart A. Randle(Interim President and Chief Executive Officer; Director)
Thryv Therapeutics is a clinical-stage biotechnology company developing selective inhibitors of serum glucocorticoid inducible kinase 1 (SGK1) for inherited cardiac arrhythmias such as Long QT Syndrome and acquired cardiometabolic diseases.
BiotechHealthtechMedical Devices
Paul F. Truex(Chairman of the Board & Chief Executive Officer)inDebra OdinkinAmy Sehnertin
Co-investorsadMare BioInnovationsAlexandriaCTI Life Sciences Fund L.P.Lumira Ventures
Thryv Therapeutics is a clinical-stage biotech developing precision-medicine treatments for genetic arrhythmia syndromes and acquired cardiometabolic diseases using selective inhibitors of serum glucocorticoid inducible kinase 1 (SGK1).
BiotechDigital HealthMedical Devices
Paul F. Truex(Chairman of the Board & Chief Executive Officer)inDebra Odink(President & Chief Development Officer)inAmy Sehnert(Chief Medical Officer)inMatt Killeen(Chief Business Officer)in
BoardSaumya Das(Chief Scientific Advisor)
Co-investorsLumira VenturesadMare BioInnovationsCTI Life Sciences Fund L.P.Fonds de solidarité FTQ
Antios Therapeutics develops antiviral therapies for hepatitis B virus (HBV) and other viral diseases, including its Active Site Polymerase Inhibitor Nucleotide (ASPIN) ATI-2173 and a capsid assembly modulator program.
BiotechHealthtechMendham, US
Gregory Mayes(Executive Officer, Director)Douglas Mayers(Executive Officer)inTamra Adams(Executive Officer)inAbel De La Rosa(Director)
BoardIyona Rajkomar(Director)inBenjamin Rovinski(Director)
Co-investorsAisling CapitalAltium CapitalAvego BioScience CapitalPontifax Venture CapitalDelos CapitalDomain Associates+8 more
BridgeBio develops treatments for genetic conditions and cancers using a decentralized hub-and-spoke model, where autonomous teams focus on specific diseases or drug candidates while a central hub provides clinical, regulatory, and commercial support.
BiotechHealthtech
Co-investorsAisling CapitalEcoR1 CapitalFrazier Life SciencesHEALTHCARE ROYALTY PARTNERSLongwood FundSequoia Capital
Contego Medical develops the Neuroguard IEP System, a 3-in-1 carotid stenting device combining a carotid stent, dilation balloon, and integrated embolic protection with a 40-micron filter to reduce stroke and cognitive impairment from microembolization.
HardwareHealthtechMedical DevicesRaleigh, US
Ravish Sachar(CEO & Founder)Paul Sanders(Chief Operating Officer)
Co-investorsHatteras Venture PartnersLightstone VenturesMountain Group CapitalUS Venture Partners
FemTechHealthtechMedical DevicesRedwood City, US
Christopher Owens(Executive Officer, Director)Darrin Uecker(Executive Officer, Director)
BoardKen Haas(Director)Jonathan MacQuitty(Director)inMike Carusi(Director)inDoug Fisher(Director)
Co-investorsBain Capital Life SciencesEndeavour VisionFemHealth VenturesKaiser Permanente VenturesKluz VenturesLightstone Ventures+5 more
HistoSonics develops histotripsy technology, a non-invasive method that uses focused sound energy to destroy targeted tissue, offered as a medical device for physicians and their patients.
BiotechHardwareHealthtechMedical DevicesAnn Arbor, GB
Thomas Davison(Executive Officer, Director)inM. Christine Gibbons(Executive Officer, Director)inWen Chen(Director)Tom Tefft(Director)Michael Blue(Executive Officer, Director)Fred Lee(Director)
Co-investorsAlpha Wave GlobalEarly Stage Partners, LPHealthQuest CapitalLumira VenturesMichigan Capital NetworkBezos Expeditions+3 more
Impulse Dynamics develops implantable medical device technology for cardiac care, with a background in biomedical research and implantable cardiac electronics.
BiotechHardwareHealthtechMedical DevicesDublin 2, US
Shlomo Ben-Haim(Director)Jason Spees(Chief Executive Officer)inPaul Bae(Chief Administrative Officer and General Counsel)inDavid Prutchi(Executive Vice President, Chief Technology Officer)inRichard J. Buchholz(Chief Financial Officer)Anthony Hong(Chief Science and Strategy Officer)in
Co-investorsAlgerBraidwellEssex Woodlands Healthcare PartnersREDMILESands Capital VenturesSignet Healthcare Partners
Inspire Medical Systems develops an FDA-approved implantable device that treats obstructive sleep apnea (OSA) by working with the patient's natural breathing, controlled via a small remote and intended for patients for whom CPAP is not effective.
Digital HealthHealthtechMedical DevicesGolden Valley, US
Tim Herbert(Founder)in
BoardMudit Jain(Director)Joyce Erony(Director)inDana Mead(Director)Chau Khuong(Director)inCasey Tansey(Director)
Co-investorsAPERTURE Venture PartnersUS Venture PartnersOrbiMed
KOKO Medical is a development-stage medical device startup building a catheter-based device that encourages uterine contractions and removes excess blood to treat postpartum hemorrhage.
FemTechHealthtechMedical DevicesExton, US
Skott Greenhalgh(Co-Founder, Chief Executive Officer)inMichael Wallace(Co-Founder, Chief Technology Officer)inJason Keiser(Co-Founder, VP of Operations)in
Miach Orthopaedics develops implants that help the body restore its own connective tissue, with an initial focus on treating ACL tears.
HealthtechMedical DevicesWestborough, US
Martha Murray(Founder)inChris Joyce(Executive Officer)inPatrick McBrayer(Executive Officer, Director)inSean Sansiveri(Director)Pieter Wolters(Director)
BoardMarc-Andre Marcotte(Director)
Co-investorsAPERTURE Venture PartnersEndeavour VisionSV Health Investors
Nervonik develops peripheral nerve stimulation (PNS) systems designed for high-motion, dynamic activity, using a patented technology that adds biosensing and objective feedback to neuromodulation.
HardwareHealthtechMedical Devices
Co-investorsFoothill VenturesLumira VenturesShangBay Capital LLCUS Venture Partners
Neuros Medical develops the Altius Direct Electrical Nerve Stimulation System, an FDA-approved implantable device that delivers patient-controlled electrical stimulation to treat chronic post-amputation pain in adult lower limb amputees.
BiotechHealthtechMedical DevicesAliso Viejo, US
David Veino(President and CEO)Zach Stassen(Chief Financial Officer)Robert J. Centa(Chief Financial Officer)Jon J. Snyder(Director, President, Secretary and CEO)in
BoardJoyce Erony(Director)inWilliam Harrington(Director)
Co-investorsAPERTURE Venture PartnersCWRU Technology VenturesiSelect FundJobsOhio VenturesJumpstart VenturesRiverVest Venture Partners+6 more
NuXcel is a global medical device accelerator that founds and incubates bioelectronics and neuromodulation startups addressing large unmet clinical needs, using a lean innovation model.
Deep TechHealthtechMedical Devices
Co-investorsTreo Ventures, LlcAPERTURE Venture PartnersNorwest Venture PartnersOSF VenturesU.S. Venture Partners
Reneo is an asset and investment management platform for decarbonizing residential real estate portfolios in Germany.
Climate TechEnterprise SoftwarePropTechGermany, DE
Lennart Börner(Founder & Co-CEO)inAlexander Graubner-Müller(Founder & Co-CEO)in
Co-investorsFoundamentalAbingworthAisling CapitalEurazeoLakestarLundbeckfonden Ventures+4 more
Xoilac TV is a free online football (soccer) live-streaming platform serving fans in Vietnam, offering Full HD match broadcasts of European, Asian, Vietnamese, and international competitions.
ConsumerMedia & EntertainmentSports Tech
Co-investorsAisling CapitalNew Enterprise Associates (NEA)Pappas CapitalRiverVest Venture PartnersAbingworthLundbeckfonden Ventures+2 more
ShiraTronics is a medical device company developing an implantable device to treat chronic migraine disease.
BiotechHardwareHealthtechMedical DevicesBrooklyn Park, US
Robert Binney(Executive Officer, Director)
BoardJoyce Erony(Director)inZack Scott(Director)inBrad Vale(Director)inCasey Tansey(Director)Mudit Jain(Executive Officer, Director)in
Co-investorsAPERTURE Venture PartnersBreakout VenturesGlobal BioAccess FundNorwest Venture PartnersOSF VenturesSeroba Life Sciences+3 more
SoundBlade Medical develops handheld histotripsy technology for non-invasive surgery, using focused ultrasound to treat tissue with precision.
HardwareHealthtechMedical Devices
Jeremy Brown(Co-Founder & CTO)inMatt Mallay(Co-Founder & Sr. Dir. R&D)inAndre Bezanson(Co-Founder & Dir. R&D)inEli Vlaisavljevich(Co-Founder)inRick Balys(Co-Founder)inNeil Barman(Chief Executive Officer)in
Co-investorsLumira VenturesAPERTURE Venture PartnersInvest Nova Scotia
Synergy is a social trading platform (in beta) where users find and follow traders, whales, and KOLs, track trending market metas, and trade together in a multiplayer mode.
Crypto & Web3FintechSocial
Co-investorsBitDAOMantle Network
Synergy Spine Solutions develops motion-preserving medical devices for patients undergoing spine surgery to treat degenerative disc disease.
HardwareHealthtechMedical Devices
Josh Butters(Chief Executive Officer)in
BoardSteve Farlow(Chairman)
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
KEW GroupSynergy Disc Replacement Inc
Exits · 4
3 IPOs · 1 acquisitions4D Molecular TherapeuticsNASDAQ: FDMTMonte Rosa TherapeuticsNASDAQ: GLUETeleflexNYSE: TFXGynesonicsacq. by Hologic
Portfolio news
latest coverage across their companiesTeleflex · investing.com · Sep 8, 2026
Inspire Medical · themarketsdaily.com · Aug 19, 2026
Synergy · equipmentfinancenews.com · Jun 25, 2026
Nervonik · citybiz.co · Apr 28, 2026
Frequently asked questions
- How many investments has Amzak Health made?
- Amzak Health has 25 tracked investments, 4 of which have exited, including 4 dated in the last 24 months.
- What stage does Amzak Health invest at?
- Amzak Health invests at the Seed, Series A, Series B, Series C, Growth, Late Stage stages.
- What sectors does Amzak Health focus on?
- Amzak Health focuses on Biotech, Digital Health, FemTech, Healthtech, Medical Devices.
- Where is Amzak Health located?
- Amzak Health is headquartered in New York, US.
- Does Amzak Health lead rounds?
- Amzak Health has led 3 of the 7 rounds where its role is on record.
- Who does Amzak Health co-invest with?
- Amzak Health most often shares deals with APERTURE Venture Partners, US Venture Partners, Aisling Capital, among 43 tracked co-investors.
Images
Co-investors · 3
Sofinnova Partners is a life sciences venture capital firm investing across the value chain from seed to later stage, with a focus on healthcare and sustainability. It backs companies in biopharma, medtech, digital medicine, agriculture and industrial processes.
Access Industries is a private holding company and global investment firm founded in 1986 by Len Blavatnik that identifies companies with strong business models and management teams to optimize their value through financial backing and strategic expertise.
Access Biotechnology invests in private and public biopharma companies developing transformative therapies for conditions with high unmet medical needs. Led by a former head of worldwide clinical R&D at Pfizer, the firm supports companies across therapeutic areas, modalities, and development stages from early-stage technology platforms to late-stage clinical programs.
Firms observed investing alongside Amzak Health, from public investor directories. Shared companies are the overlap with Amzak Health's recorded portfolio.
Similar investors
Portfolia operates venture funds designed by and for women, enabling members to invest collectively in innovative companies while learning together through curated content, founder access, and hands-on deal flow.
WELL Health Ventures is the corporate venture arm of WELL Health Technologies, backing digital health companies with an emphasis on modernizing healthcare in Canada.
Ontario Centre of Innovation (OCI) is a government-supported organization that funds and supports the development, commercialization, and adoption of advanced technologies in Ontario, connecting industry, academia, and entrepreneurs.
Heliad is a publicly listed evergreen investment firm that backs founders from early stage through IPO and beyond, providing access to capital markets via its balance sheet and its early-stage vehicle Collective Ventures.
500 Global (formerly 500 Startups) is a venture capital firm whose flagship Silicon Valley strategy backs promising technology companies from pre-seed onward across a range of sectors and geographies.